Linked research, clinical, and regulatory source pathways.
Company profile
About Cadence
Cadence is a clinical AI company that automates chronic disease management for health systems, payers, and medical groups. The company's Clinical Intelligence platform combines AI agents with a multidisciplinary care team to provide continuous monitoring, medication titration, and proactive intervention for patients with chronic conditions between clinical visits. Cadence's technology integrates directly into existing EMR workflows, enabling physicians to manage larger patient panels without additional burden. The platform tracks vitals, symptoms, medications, and engagement data, using AI to flag risks early and automate protocol-driven decisions while keeping physicians in control. Cadence offers three primary care models: 24/7 Preventive Primary Care (a Medicare-covered model for PCPs), Remote Patient Care (daily vitals monitoring and treatment), and Post-Acute Care (post-discharge support). The company is trusted by over 20 health systems and has enrolled more than 85,000 patients. Cadence's approach has demonstrated peer-reviewed clinical outcomes including a $1,302 decrease in total cost of care per patient per year, 27% reduction in hospital admissions, and significant improvements in blood pressure control and medication adherence. The company is on a mission to deliver life-changing treatment to 1 million people with chronic conditions by the end of the decade.
Company description Cadence official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- chronic diseases
- heart failure
- hypertension
- post-acute care
- stroke
- type 2 diabetes
Who it serves
- Clinicians
- Health Systems
- Medical groups
- Payers
Deployment & integration
Deployment information is currently being developed.
Geographic context
Company milestones
Platform expansion
$100M Series C funding led by Spark Capital (June 2026), CMS ACCESS Model participation confirmed (March 2026), launched AI-powered Proactive Care Engine (July 2025), named to 2024 LinkedIn Top Startups List, multiple health system partnerships announced 2025-2026
Partnerships
Recorded partners
- Community Health Systems
- Duke Health
- Hackensack Meridian Health
- Hartford HealthCare
- Mayo Clinic
- Memorial Hermann
- Providence
- Texas Health Resources
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Impact of a Nationwide Remote Patient Care Hypertension Program on Clinical and Health Care Cost and Utilization Outcomes.Mayo Clinic proceedings · Aug 27, 2026
Coalescence of suspended and sessile isotropic and radial nematic liquid crystal drops.Soft matter · Aug 4, 2026
AlphaGo-driven generative machine learning framework for inverse topology synthesis and optimization of planar antennas.Scientific reports · Jul 9, 2026
A computational analysis of the glycoprotein LRP1 structure and the role of glycans as quaternary glue.Bioinformatics (Oxford, England) · Jun 4, 2026
Kainic acid pig model of hippocampal epilepsy.Scientific reports · Jun 4, 2026
Epicardial adipose tissue signatures in Asian coronary artery disease: Insights from cardiac CT.American journal of preventive cardiology · Jun 1, 2026
Clinical validation
Clinical-trial records
Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's PatientsNCT06975059 · Mentioned · SUSPENDED
Training and Testing Database for IMU Based Gait Analysis MethodsNCT07236008 · Mentioned · RECRUITING
Adaptive Self-Efficacy-Based AI Coaching for CyclingNCT07318233 · Mentioned · RECRUITING
Rehabilitation Assessment of Motor Function In Cerebral Palsy Using Explainable AINCT07629024 · Mentioned · NOT YET RECRUITING
Gait Analysis in Neurological DiseaseNCT02994719 · Mentioned · ACTIVE NOT RECRUITING
Inspiring Seniors Towards Exercise Promotion - 2NCT07629739 · Mentioned · RECRUITING
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Mayo Clinic Proceedings study, February 2026
Mayo Clinic Proceedings study
Mayo Clinic Proceedings study
Mayo Clinic Proceedings study
NEJM Catalyst, October 2025
NEJM Catalyst study
NEJM Catalyst study
Journal of Cardiac Failure, September 2024
JACC Advances, July 2025
Heart failure study, November 2025
Heart failure study across 1,786 patients
2025 operations
2025 operations
2025 operations
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Cadence
Recent articles published on Cadence's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Chronic Disease Management & Digital Therapeutics
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.